Critical Path Institute (C-Path) Type 1 Diabetes Consortium Executive Director Joe Hedrick and Senior Director of Digital and Precision Medicine Sakshi Sardar lead the session, "Transformative Tools to Capture Early Stages of Disease: Digital Health Technologies (DHTs), Making the Invisible, Visible — – DHTs as Drug Development Tools (DDTs) at C-Path's Global Impact Conference 2024.
SUBSCRIBE to C-Path's YouTube Channel Now ►► [ Ссылка ]
FOLLOW C-Path:
►LinkedIn: [ Ссылка ]
►Facebook: [ Ссылка ]
►Twitter: [ Ссылка ]
About Critical Path Institute
C-Path is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org.
#CPath #drugdiscovery #researchgrants #globalhealth #drugdevelopment #datasharing #researchfunding #raredisease #academicresearch #regulatoryscience #globalhealth #consortia #collaboration #FDA #EMA #T1D #Parkinsons #Alzheimers #PKD #Duchenne #ALS #biomarkers #parkinsons #cgic24
